A HISTORY CASE OF ADALIMUMAB TREATMENT IN A FEMALE PATIENT WITH JUVENILE ARTHRITIS AND UVEITIS AS MANIFESTATIONS OF CROHN’S DISEASE
https://doi.org/10.15690/vsp.v12i4.749
Abstract
A history case of severe juvenile arthritis with uveitis as manifestations of Crohn’s disease, resistant to standard immunosuppressive therapy and treatment with chimeric anti-tumor necrosis factor-alpha monoclonal antibody is represented in this article. Adalimumab — recombinant monoclonal antibody, which peptides sequence is identical to human IgG1, allowed to arrest active stage of inflammatory process, uveitis and intestinal manifestations of Crohn’s disease, as well as to restore function of involved joints almost completely. This history case confirms high efficacy of adalimumab in patients with Crohn’s disease manifested with juvenile arthritis complicated with uveitis, and allow to recommend this medicine as first-line genetically-engineered biological agent in treatment of such patients.
About the Authors
V. A. Malievskii
Bashkortostan State Medical University, Ufa, Republic of Bashkortostan
Russian Federation
Malievskii Viktor Arturovich, PhD, professor of Department of Clinical Pediatrics of Bashkir State Medical University
Russian Federation
Malievskii Viktor Arturovich, PhD, professor of Department of Clinical Pediatrics of Bashkir State Medical University
A. A. Nijevitch
Bashkortostan State Medical University, Ufa, Republic of Bashkortostan
Russian Federation
Russian Federation
E. P. Pervushina
Republican Pediatric Clinical Hospital, Ufa
Russian Federation
Russian Federation
L. Yu. Sapronova
Republican Pediatric Clinical Hospital, Ufa
Russian Federation
Russian Federation
References
1. Cassidy J., Petty R. Textbook of Pediatric Rheumatology. Philadelphia: Saunders Elsevier. 2011.
2. Malievskii V. A. Yuvenil'nye artrity: epidemiologiya, medikosotsial'nye i ekonomicheskie posledstviya, kachestvo zhizni. Avtoref. diss. … dokt. med. nauk [Juvenile arthritis: epidemiology, medicosocial and economic consequences, quality of life. Author’s abstract]. Moscow, 2006. 38 p.
3. Hofer M., Southwood T. Classification of childhood arthritis. Best Pract. Res. Clin. Rhematol. 2002; 16 (3): 379–396.
4. Alekseeva E. I., Litvitskii P. F. Yuvenil'nyi revmatoidnyi artrit: etiologiya, patogenez, klinika. Algoritmy diagnostiki i lecheniya [Juvenile Rheumatoid Arthritis: Etiology, Pathologic Behavior, Clinical Picture. Algorithms of Diagnosis and Treatment]. Moscow, Vedi, 2007. 368 p.
5. Baranov A. A., Alekseeva E. I., Bzarova T. M., Valieva S. I., Denisova R. V., Isaeva K. B., Karagulyan N. A., Litvitskii P. F., Mitenko E. V., Sleptsova T. V., Fetisova A. N., Chistyakova E. G., Taibulatov N. I., Morev S.Yu. Voprosi sovremennoi pediatrii — Current Pediatrics. 2013; 12 (1): 37–56.
6. Goryainov S. V., Avksent'eva M. V., Omel'yanovskii V. V. Meditsinskie tekhnologii: otsenka i vybor — Medical Technologies. Assessment and Choice. 2011; 4 (6): 9–16.
7. Lovell D., Rupetto N., Goodman S. Adalimumab with or without methtrexate in juvenile rheumatoid frthritis. N. Engl. J. Med. 2008; 359 (8): 810–820.
8. Alekseeva E. I., Mitenko E. V., Valieva S. I. etc. Voprosi sovremennoi pediatrii — Current Pediatrics. 2012; 11 (1): 111–118.
9. Simonini G., Taddio A., Cattani M. et al. Prevention of flare recurrences in childhood-refractory chronic uveitis: an open-label comparative study of adalimumab versus infliximab. Arthr. Care & Res. 2011; 63 (4): 612–618.
10. Rudakova A. V. Pediatricheskaja farmokologija — Pediatric pharmacology. 2012; 8 (4): 55–58.
11. Colombel J.-F., Sandborn W. J., Rutgeerts P. et al. Adalimumab for maintenance of clinical response and remission in patients with Cron’s disease: the CHARM trial. Gastroenterology. 2007; 132 (1): 52–65.
12. Rutgeerts P. et al. Adalimumab induces and maintains mucosal healing in patients with Cron’s disease: Data from the EXTEND Trial. Gastroenterology. 2012; 1102–1111.
13. Tsimbalova E. G., Potapov A. E., Venediktova M. M. Voprosi sovremennoi pediatrii — Current Pediatrics. 2012; 11 (1): 135–142.
14. Shumilov P. V., Shchigoleva N. E., Ipatova M. G. etc. Voprosi prakticheskoi pediatrii — Problems of Practical Pediatrics. 2010; 5 (1): 23–30.
Review
For citations:
Malievskii V.A., Nijevitch A.A., Pervushina E.P., Sapronova L.Yu. A HISTORY CASE OF ADALIMUMAB TREATMENT IN A FEMALE PATIENT WITH JUVENILE ARTHRITIS AND UVEITIS AS MANIFESTATIONS OF CROHN’S DISEASE. Current Pediatrics. 2013;12(4):181-184. (In Russ.) https://doi.org/10.15690/vsp.v12i4.749
Views:
712
Email this article 
